| abstract |
ThenInvention relates to a transdermal therapeutic system (TTS),npreferably in the form of a transdermal patch containing an active ingredient,ncontains an agent rendering the drug useless and an agent whichncauses, when removing the TTS from the skin of the patient drug,nz. Buprenorphine, and agent, e.g. As potassium permanganate, with each othernin touchncome and by this contact the active substance is destroyed. |